A unique treatment for Parkinson’s disease is about to be tested in Japan, with the first clinical trial scheduled to begin on August 1. The announcement was made on July 30 by the Kyoto University Hospital, which started patient recruitment on the same day at 5 p.m. local time, reports Science Magazine.
This innovative treatment is based on a special type of stem cells known as induced pluripotent stem (iPS) cells, discovered in 2006 by Japanese researcher Shinya Yamanaka.
As the Inquisitr previously reported, pluripotent stem cells are extremely versatile and have the advantage of evolving into any type of cells once transplanted into the body. But while these are typically embryonic stem cells (used for a wide array of medical applications), Yamanaka has found a way to manipulate adult stem cells and infect them with a virus that restores them to their immature state.
0 comments :
Post a Comment